Ferric Pyrophosphate Citrate is popular as an iron replacement mineral salt. It treats low iron levels in patients receiving hemodialysis therefore added to the solution used in dialysis machines. Injectable & LR Grade available.
Molecular Formula – C18H24Fe4O42P6
Molecular Weight – 1321.57 gm/mol
CAS No – 1802359-96-1
Shelf Life – 36 months
HSN Code – 2835.3900
Packing Size – 20 kg in sterile HDPE drum
Storage Condition – Keep Well Closed, protected against light, dry and at room temperature
Additional Info – 1. Only manufacturer in India
2. Very suitable for iron suplementation during dialysis
3. Non – infringing process
| SL# | PARAMETER | SPECIFICATION |
| 1. | Description | Apple green free flowing powder. |
| 2. | Solubility | Freely soluble in water, insoluble in alcohol. |
| 3. | Identification | Positive for Iron, Pyrophosphates and Citrates. |
| 4. | Arsenic | NMT 3 ppm. |
| 5. | Lead | NMT 10 ppm. |
| 6. | Mercury | NMT 3 ppm. |
| 7. | LOD (at 105°C till constant weight) | NMT 10.0% w/w. |
| 8. | Assay (of Iron) (On Dried Basis) | 10.0% w/w – 13.0% w/w. |
| 9. | Total Microbial Count | NMT100 cfu/gm. |
| 10. | Total Combined Moulds/Yeast | NMT 10 cfu/gm. |
| 11. | Pathogenic Organism | Must be absent. |
| 12. | Bacterial Endotoxin | NMT 12.87 EU/mg. |
Abstract Anemia is a common complication in patients with hemodialysis-dependent chronic kidney disease (HDD-CKD). Anemia is principally the result of erythropoietin deficiency, inflammation, and iron deficiency. High molecular weight iron oxide nanoparticles (IONP) are routinely administered intravenously to replace iron...
Read moreAbstract Treatment of anemia remains an integral component in the care of patients with end stage kidney disease receiving dialysis. Currently, both erythropoiesis stimulating agents and iron replacement agents remain important anemia management strategies for patients undergoing hemodialysis (HD). Ferric...
Read more